Identification and prioritization of novel therapeutic candidates against glutamate racemase from Klebsiella pneumoniae.
<h4>Background</h4>Klebsiella pneumoniae, a gram-negative bacterium in the Enterobacteriaceae family, is non-motile, encapsulated, and a major cause of nosocomial infections, particularly in intensive care units. The bacterium possesses a thick polysaccharide capsule and fimbriae, which...
Saved in:
Main Authors: | Ankit Kumar, Farah Anjum, Md Imtaiyaz Hassan, Anas Shamsi, Rashmi Prabha Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0317622 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01) -
Genome Characteristic of NDM-5-Producing Klebsiella Quasipneumoniae and Klebsiella Pneumoniae in China
by: Chen L, et al.
Published: (2025-02-01) -
Disruption of zinc homeostasis reverses tigecycline resistance in Klebsiella pneumoniae
by: Jinyu Wang, et al.
Published: (2025-02-01) -
Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
by: Yan T, et al.
Published: (2025-02-01) -
Comparative analysis of selected methods of carbapenemase determination among clinical Klebsiella pneumoniae.
by: Agata Pruss, et al.
Published: (2025-01-01)